Private Equity
Madrid-based MedLumics, a medical device company, has named James Greene as CEO and Giovanni Leo to its board of directors. Previously, Greene worked at Seroba Lifesciences, a Dublin-based venture firm where he was a partner while Leo was vice president of research and development for St. Jude Medical. MedLumics' backers include Edmond de Rothschild Investment Partners, Seroba Lifesciences, Innogest, Ysios and Caixa.
4 min read · 28 November 2017
Govtech Fund has raised $20.75 million toward a targeted $25 million second fund, according to a regulatory filing. The San Francisco-based firm invests in startups in the global government software and IT market, according to its website, and is led by Ron Bouganim. Thus far, 29 investors have committed to the fund.
1 min read · 27 November 2017
Silicon Valley-based NeoTribe Ventures, an early-stage venture firm, has raised $113.5 million for its debut fund, according to an SEC filing. The target is $130 million.
1 min read · 27 November 2017
4 min read · 27 November 2017
London-based venture firm Balderton Capital has raised $375 million for its latest fund that will focus on European tech businesses. Fried Frank advised Balderton on the fund.
3 min read · 27 November 2017
San Mateo, California-based Medeor Therapeutics Inc, a developer of personalized cellular immunotherapies, has raised $57 million in Series B financing. RA Capital Management led the round with participation from other investors that included Sofinnova Ventures, 6 Dimensions Capital, Vivo Capital and WuXi Healthcare Ventures. In conjunction with the financing, Dr. Peter Kolchinsky, a portfolio manager and managing director at RA Capital and Dr. Anand Mehra, general partner at Sofinnova Ventures, have joined the Medeor's board of directors.
1 min read · 27 November 2017
San Diego-based Biolinq, a digital health company, has raised $10 million in Series A financing. The investors included M Ventures, Hikma Ventures, Grey Sky Venture Partners, Three Leaf Ventures and LifeSci Venture Partners.
1 min read · 27 November 2017
4 min read · 27 November 2017
Startup accelerator Bioindustrial Innovation Canada (BIC) has agreed to partner with five venture capital firms to capitalize emerging companies in Canada's bioeconomy and clean technology sectors. ArcTern Ventures, Cycle Capital Management, Fraser Mackenzie Merchant Capital and Greensky Capital of Canada and France's Sofinnova Partners will work with BIC to explore opportunities to co-invest in BIC portfolio companies. Sarnia, Ontario-based BIC supports early-stage companies focused on converting renewable resources into value-added bioenergy, biofuel, biochemicals and biomaterials.
4 min read · 24 November 2017
Techstars Ventures is raising a $400 million venture capital fund, according to a filing with the SEC.
1 min read · 22 November 2017
